|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2001-10-19
|
|
pubmed:abstractText |
A combination of low-dose aspirin with anticoagulants may provide better protection against thromboembolic events compared to anticoagulants alone in high-risk patients with atrial fibrillation.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1015-9770
|
|
pubmed:author |
pubmed-author:Chaumet-RiffaudPP,
pubmed-author:DerumeauxGG,
pubmed-author:FFAACS (Fluindione, Fibrillation Auriculaire, Aspirin et Contraste...,
pubmed-author:LacomblezLL,
pubmed-author:LardouxHH,
pubmed-author:LechatPP,
pubmed-author:LecompteTT,
pubmed-author:MaillardLL,
pubmed-author:MalletAA,
pubmed-author:MarJ MJM,
pubmed-author:MentreFF,
pubmed-author:PisicaGG,
pubmed-author:PoussetFF,
pubmed-author:RaynaudPP,
pubmed-author:SanchezPP,
pubmed-author:Solbes-LatouretteSS
|
|
pubmed:copyrightInfo |
Copyright 2001 S. Karger AG, Basel
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
12
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
245-52
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11641591-Administration, Oral,
pubmed-meshheading:11641591-Aged,
pubmed-meshheading:11641591-Anticoagulants,
pubmed-meshheading:11641591-Aspirin,
pubmed-meshheading:11641591-Atrial Fibrillation,
pubmed-meshheading:11641591-Dose-Response Relationship, Drug,
pubmed-meshheading:11641591-Double-Blind Method,
pubmed-meshheading:11641591-Drug Combinations,
pubmed-meshheading:11641591-Female,
pubmed-meshheading:11641591-Hemorrhage,
pubmed-meshheading:11641591-Humans,
pubmed-meshheading:11641591-Male,
pubmed-meshheading:11641591-Phenindione,
pubmed-meshheading:11641591-Risk Factors,
pubmed-meshheading:11641591-Thromboembolism,
pubmed-meshheading:11641591-Treatment Outcome,
pubmed-meshheading:11641591-Vascular Diseases
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Anticoagulant (fluindione)-aspirin combination in patients with high-risk atrial fibrillation. A randomized trial (Fluindione, Fibrillation Auriculaire, Aspirin et Contraste Spontané; FFAACS).
|
|
pubmed:affiliation |
Pharmacology Department, Pitié-Salpêtrière Hospital, Paris, France. philippe.lechat@ps1.ap-hop-paris.fr
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
